Eficacia de la premedicación con un esteroide y un antihistamínico en la prevención de reacciones infusionales por infliximab
Authors:
- Fernando BermejoFBFernando Bermejo
- Antonio López San RománARAntonio López San Román
- Alicia AlgabaAAAlicia Algaba
- Manuel Van DomselaarMDManuel Van Domselaar
- José A. CarnerosJCJosé A. Carneros
- Miguel RiveroMRMiguel Rivero
- Belén PiquerasBPBelén Piqueras
- M. Paz ValerMVM. Paz Valer
- 1 December 2008
- journal article
- abstracts
- Published by Elsevier in Gastroenterología y Hepatología
- Vol. 31 (10) , 629-632
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- Infusion reactions and their managementGastroenterology Clinics of North America, 2006
- Association of Trough Serum Infliximab to Clinical Outcome After Scheduled Maintenance Treatment for Crohn’s DiseaseClinical Gastroenterology and Hepatology, 2006
- Infliximab Maintenance Therapy for Fistulizing Crohn's DiseaseNew England Journal of Medicine, 2004
- The safety profile of infliximab in patients with Crohn’s disease: The Mayo Clinic experience in 500 patientsGastroenterology, 2004
- The Incidence and Management of Infusion Reactions To Infliximab: A Large Center ExperienceAmerican Journal of Gastroenterology, 2003
- Intravenous hydrocortisone premedication reduces antibodies to infliximab in Crohn's disease: A randomized controlled trialGastroenterology, 2003
- Influence of Immunogenicity on the Long-Term Efficacy of Infliximab in Crohn's DiseaseNew England Journal of Medicine, 2003
- Infusion reactions to infliximab in children and adolescents: frequency, outcome and a predictive modelAlimentary Pharmacology & Therapeutics, 2002
- Maintenance infliximab for Crohn's disease: the ACCENT I randomised trialThe Lancet, 2002
- Classification of Inflammatory Bowel DiseaseScandinavian Journal of Gastroenterology, 1989